Competitor Analysis: COVID-19 Vaccines in Development

Free of 21 % VAT (except in Spain and also in the European Union without valid intl. VAT no), delivery costs do not apply.

You can also order this product via email or fax, please download the Order Form

Publisher: La Merie Publishing
Pages: 23
Format: PDF
Product Line: Competitor Analysis
Product Code: LMCA0183
Release Date: March of 2020

Competitor Analysis: COVID-19 Vaccines in Development

This Competitive Intelligence report about COVID-19 Vaccines in Development describes the landscape of industry-driven approaches to discover and develop vaccines for prevention of COVID-19 as of March 27, 2020.

COVID-19 is caused by SARS-CoV-2, which belongs to a group of viruses called coronaviruses that attack the respiratory system. There is currently no licensed vaccine, treatment or cure for COVID-19. Since the outbreak of the SARS-CoV-2 pandemia, industry alone or in collaborative efforts rapidly have initiated work to generate vaccine candidates to prevent COVID-19 based on a variety of technologies, including

  • mRNA
  • vector/vectorized cells
  • DNA
  • recombinant subunit
  • live, attenuated virus
  • different adjuvants

Clinical evaluation of the first COVID-19 vaccine candidates has begun and a total at least 34 vaccine approaches to prevent COVID-19 are in the pipeline.

This report includes a compilation of industry-driven projects in research and development of SARS-CoV-2 targeted vaccines for prophylaxis of COVID-19. Competitor projects are listed in a tabular format providing information on:

  • Drug Codes,
  • Target / Mechanism of Action,
  • Class of Compound,
  • Company,
  • Product Category,
  • Indication,
  • R&D Stage and
  • additional comments with a hyperlink leading to the source of information.

About Competitor Analysis Series:
The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies. The information is provided in a tabular format and fully referenced.


Custom Support & Sale:

Mon–Fri: 10:00 am –5:00 pm GMT+01